Eastwood Bio-Medical Canada Inc. (TSXV:EBM)

TSXV:EBM Revenue

Eastwood Bio-Medical Canada had revenue of 149.79K CAD in the quarter ending July 31, 2026, with 19.40% growth. This brings the company's total for the last twelve months to 812.12K, up 36.59% year-over-year. In the fiscal year ending October 31, 2025, Eastwood Bio-Medical Canada had annual revenue of 782.08K with 11.40% growth. That makes Eastwood Bio-Medical Canada the 44,389th largest company in the world by revenue and 940th in Canada.

• Revenue (ttm): 812.12K
• Revenue Growth: +36.59%
• P/S Ratio: 148.44
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 120.55M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Asia 619.49K 79.2%
• Canada 86.26K 11.0%
• United States (U.S.) 76.34K 9.8%

Fiscal year ended Oct 31, 2025 See the full TSXV:EBM breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Oct 31, 2025	782.08K	80.00K	11.40%
Oct 31, 2024	702.08K	-165.86K	-19.11%
Oct 31, 2023	867.94K	-431.83K	-33.22%
Oct 31, 2022	1.30M	318.71K	32.49%
Oct 31, 2021	981.05K	262.72K	36.57%

Data Source: S&P Global Market Intelligence Last updated: Sep 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error